IRIS - Res&Arch Institutional Research Information System - Research & Archive

CALABRESI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.505
EU - Europa 11.855
AS - Asia 9.018
SA - Sud America 2.180
AF - Africa 166
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 12
Totale 37.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.240
SG - Singapore 4.159
UA - Ucraina 2.289
IE - Irlanda 2.105
BR - Brasile 1.864
IT - Italia 1.809
SE - Svezia 1.375
VN - Vietnam 1.323
CN - Cina 1.271
RU - Federazione Russa 1.269
HK - Hong Kong 1.210
DE - Germania 791
FI - Finlandia 633
FR - Francia 458
GB - Regno Unito 385
KR - Corea 383
NL - Olanda 124
AR - Argentina 121
CA - Canada 120
TR - Turchia 109
PL - Polonia 107
IN - India 99
MX - Messico 91
AT - Austria 83
CH - Svizzera 80
CZ - Repubblica Ceca 70
RO - Romania 67
BD - Bangladesh 65
ID - Indonesia 63
ZA - Sudafrica 61
JP - Giappone 59
EC - Ecuador 55
BE - Belgio 54
IQ - Iraq 53
UZ - Uzbekistan 52
ES - Italia 43
VE - Venezuela 31
LT - Lituania 29
GR - Grecia 28
MA - Marocco 26
CO - Colombia 23
PK - Pakistan 23
EU - Europa 22
LB - Libano 21
PE - Perù 20
PY - Paraguay 20
UY - Uruguay 20
CL - Cile 18
SA - Arabia Saudita 17
KE - Kenya 16
EG - Egitto 14
AZ - Azerbaigian 13
DZ - Algeria 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
KZ - Kazakistan 10
JO - Giordania 9
AU - Australia 8
NP - Nepal 8
AL - Albania 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
XK - ???statistics.table.value.countryCode.XK??? 7
BG - Bulgaria 6
BO - Bolivia 6
CI - Costa d'Avorio 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
RS - Serbia 6
HN - Honduras 5
HU - Ungheria 5
OM - Oman 5
PA - Panama 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BB - Barbados 4
GT - Guatemala 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
TW - Taiwan 4
BY - Bielorussia 3
CG - Congo 3
CR - Costa Rica 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
ET - Etiopia 2
GA - Gabon 2
GM - Gambi 2
Totale 37.728
Salva come PNG Salva come JPEG
Città #
Singapore 2.755
Chandler 2.392
Dublin 2.100
Hong Kong 1.201
Jacksonville 1.147
San Mateo 1.146
Boardman 849
Dong Ket 648
Ashburn 644
Santa Clara 597
Medford 536
Princeton 532
Perugia 509
Altamura 490
Wilmington 401
Lawrence 388
Seoul 377
Moscow 374
Des Moines 364
Andover 343
Beijing 313
Ann Arbor 308
Ho Chi Minh City 246
Munich 216
Los Angeles 193
São Paulo 158
Piscataway 151
Saint Petersburg 147
Hanoi 133
New York 104
The Dalles 104
Helsinki 99
Norwalk 97
Turku 89
San Paolo di Civitate 83
Falls Church 78
Woodbridge 77
Redmond 69
Izmir 68
Milan 65
Warsaw 63
Rio de Janeiro 62
Shanghai 62
Rome 56
Brussels 53
Bucharest 53
Frankfurt am Main 53
Tokyo 52
Brooklyn 51
Houston 49
Denver 48
Stockholm 48
Dearborn 45
London 44
Orem 43
Montreal 41
Chennai 39
Chicago 39
Johannesburg 39
Atlanta 38
Brno 38
Columbus 36
Boston 34
Phoenix 34
Belo Horizonte 33
Redwood City 32
San Francisco 32
Brasília 31
Curitiba 31
Dallas 31
Den Haag 29
Haiphong 29
Mexico City 29
Poplar 29
Amsterdam 27
Nuremberg 26
Seattle 26
Tashkent 26
Toronto 26
Porto Alegre 25
Falkenstein 24
Manchester 23
Campinas 22
Guangzhou 22
Ankara 21
Da Nang 21
Olomouc 21
Vienna 20
Fortaleza 19
Guarulhos 19
Bologna 18
Hải Dương 18
Quito 18
Salvador 18
Zhengzhou 18
Biên Hòa 17
Charlotte 17
Guayaquil 17
Lausanne 17
Maceió 16
Totale 22.559
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 653
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 197
CSF and blood biomarkers for Parkinson's disease 173
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 154
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 133
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 132
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 132
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 130
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 124
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 123
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? 122
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 122
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 121
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 119
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. 117
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 114
Hippocampal epileptogenesis in autoimmune encephalitis 111
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 111
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 110
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. 109
Acute dystonia induced by the combination of midodrine and perphenazine. 109
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 109
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 108
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 108
Brain arteriovenous malformations and seizures: an Italian study. 108
Phyto-oestrogens in the prophylaxis of menstrual migraine. 107
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. 107
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 107
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 107
Cell-type specificity of mGluR activation in striatal neuronal subtypes. 106
Cerebrospinal fluid biomarkers in Parkinson disease. 106
Dural arteriovenous fistulas and headache features: an observational study 106
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 105
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. 105
A magnetization transfer study of mild and advanced Parkinson's disease. 105
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. 104
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 104
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 104
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 104
Clinical aspects and management of levodopa-induced dyskinesia. 103
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 103
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 103
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 103
Deficits of glutamate transmission in the striatum of experimental hemiballism. 102
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 102
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 102
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 101
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 101
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. 100
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. 100
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 100
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 100
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 100
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. 99
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 99
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 99
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 99
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 99
Calcium signaling and neuronal vulnerability to ischemia in the striatum. 98
Modulation of gene expression following long-term synaptic depression in the striatum. 98
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 98
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 98
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. 98
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 98
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 98
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 98
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 98
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 98
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. 97
Plasticity and repair in the post-ischemic brain 97
Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? 96
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. 96
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 96
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 96
Diagnostic accuracy of Parkinson disease by Support Vector Machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age 96
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. 95
Occipital arteriovenous malformations andmigraine. 95
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 95
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 95
Pathological Synaptic Plasticity in the Striatum: Implications for Parkinson's Disease. 94
Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. 94
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. 94
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. 94
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 94
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 94
Lysosomal enzyme activities in human brain 94
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 94
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 94
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 94
Removing Pathogenic Memories: A Neurobiology of Psychotherapy. 93
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. 93
Association between migraine and headache attributed to stroke: a case-control study. 93
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 93
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 92
Migraine with aura in the locker room: three case reports. 92
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 92
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 92
Bidirectional Synaptic Plasticity Is Driven by Sex Neurosteroids Targeting Estrogen and Androgen Receptors in Hippocampal CA1 Pyramidal Neurons 91
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 91
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. 90
Totale 11.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.407 0 0 0 0 0 263 293 73 535 153 370 720
2021/20224.441 88 792 110 257 135 55 55 1.426 88 162 475 798
2022/20237.804 619 1.432 157 639 586 979 10 314 2.704 20 257 87
2023/20242.712 166 310 154 59 31 18 433 134 361 92 448 506
2024/20256.587 114 669 226 270 813 325 311 568 1.343 432 932 584
2025/20268.378 1.074 1.083 877 2.231 1.893 1.220 0 0 0 0 0 0
Totale 38.891